Lower riskMedical device recall · FDA · Published February 21, 2019
Becton Dickinson BD Synapsys Software Version 2.1 May Cause Incorrect Test Orders
Becton Dickinson recalls BD Synapsys software version 2.1 due to potential incorrect test order associations with culture records. Affected users should check their software version and contact support for details.
Becton Dickinson is recalling BD Synapsys laboratory software version 2.1 because it could link test orders to the wrong culture records. This error might lead to incorrect lab results, but the recall does not mention any injuries or immediate safety risks. Read more at govinfonow.com/recall/68965-becton-dickinson-bd-synapsys-software-version-2-1-may-cause.
“Becton Dickinson BD Synapsys Software Version 2.1 May Cause Incorrect Test Orders.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/68965-becton-dickinson-bd-synapsys-software-version-2-1-may-cause. Based on FDA recall #Z-1051-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1051-2019%22&limit=1).
Becton Dickinson & Co. recalled BD Synapsys Laboratory Solutions (Catalog No. 444150) on Feb. 21, 2019, according to the FDA. The software version 2.1 allowed test orders to be associated with incorrect culture records.
How to tell if you have it
Brand: Becton Dickinson
Product: BD Synapsys Laboratory Solutions
Catalog Number: 444150
Version: 2.1
UDI: 00382904441500
The hazard
BD Synapsys version 2.1 allowed the potential for a test order to be associated to an incorrect culture record.
Context
GovInfoNow's records show Becton Dickinson & Co. has 43 other recalls on record since June 1, 2017. Other recent recalls of similar products include BD GasP: CO2 Pouch System Recall (April 7, 2026), BD Kiestra Isolate Suspension Cuvette Array (Oct. 23, 2025), and Product Catalog (Sept. 23, 2025).
How to tell if you have this one
Check if your BD Synapsys software version is 2.1 with catalog number 444150. The software is used for laboratory data management in clinical diagnostics.
Brand
Becton Dickinson
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Software Version
Verify your BD Synapsys software version is 2.1 with catalog number 444150.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 4 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide Distribution - US: Nationwide in the states of OH, IL, MO, TN and the countries of Netherlands” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Illinois, Missouri, Ohio, Tennessee.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1051-2019 (February 21, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1051-2019 to see it in context.
Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.